Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma-Reference-Cited by-同舟云学术

Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma

Published:2018-01 Issue:1 Volume:13 Page:124-133
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Patil Namrata S.,Righi Luisella,Koeppen Hartmut,Zou Wei,Izzo Stefania,Grosso Federica,Libener Roberta,Loiacono Marco,Monica Valentina,Buttigliero Consuelo,Novello Silvia,Hegde Priti S.,Papotti Mauro,Kowanetz Marcin,Scagliotti Giorgio V.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England;Damhuis;Lung Cancer,2015

2. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

3. Systemic treatment of malignant pleural mesothelioma;Grosso;Future Oncol,2012

4. The established and future biomarkers of malignant pleural mesothelioma;Panou;Cancer Treat Rev,2015

5. Tumours of the Lung, Pleura, Thymus and Heart,2015

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy;Cancers;2023-12-10

2. Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group;Current Problems in Cancer;2023-12

3. Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial;Journal for ImmunoTherapy of Cancer;2023-08

4. Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients;Cancers;2023-07-14

5. Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma;Frontiers in Toxicology;2023-06-27